Maxeran en es it fr

Maxeran Brand names, Maxeran Analogs

Maxeran Brand Names Mixture

  • No information avaliable

Maxeran Chemical_Formula


Maxeran RX_link

Maxeran fda sheet

Maxeran FDA

Maxeran msds (material safety sheet)

Maxeran MSDS

Maxeran Synthesis Reference

Thominet, U.S. Pat. 3,177,252 (1965)

Maxeran Molecular Weight

299.796 g/mol

Maxeran Melting Point

147.25 oC

Maxeran H2O Solubility

200 mg/L

Maxeran State


Maxeran LogP


Maxeran Dosage Forms

Liquid; Syrup; Tablet

Maxeran Indication

For the treatment of gastroesophageal reflux disease (GERD)

Maxeran Pharmacology

Metoclopramide, although chemically related to procainamide, does not possess local anesthetic or antiarrhythmic properties. Metoclopramide is used to enhance GI motility, to treat diabetic gastroparesis, as an antinauseant, and to facilitate intubation of the small bowel during radiologic examination. Metoclopramide may be used to treat chemotherapy-induced emesis and as a radiosensitizing agents in the treatment of non-small cell lung carcinoma and glioblastomas in the future.

Maxeran Absorption

Rapidly and well absorbed (oral bioavailability 80±15.5%).

Maxeran side effects and Toxicity

Oral, mouse LD50: 280 mg/kg. Signs of overdose include drowsiness, disorientation, and extrapyramidal reactions.

Maxeran Patient Information

Maxeran Organisms Affected

Humans and other mammals